awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28550228-0B14B4AC-492C-4B33-A476-5E995794D96E
Q28550228-0B14B4AC-492C-4B33-A476-5E995794D96E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28550228-0B14B4AC-492C-4B33-A476-5E995794D96E
Addition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case Series
P2860
Q28550228-0B14B4AC-492C-4B33-A476-5E995794D96E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28550228-0B14B4AC-492C-4B33-A476-5E995794D96E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
829e7e17331094faf2c7b17123159bf59dd246ea
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.